ADVERTISEMENT
 |
|
Top Stories
Paul Hudson, formerly CEO of Novartis Pharmaceuticals, has been tapped to succeed Olivier Brandicourt as CEO of Sanofi.
/ read more /
The acquisition will boost Biogen's gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.
/ read more /
|
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
A new United Kingdom life-science asset, HIRANI, was launched at a reception at BIO 2019.
/ read more /
Jefferson established the Jefferson Institute for Bioprocessing workforce training institute in collaboration with NIBRT using the GE Healthcare FlexFactory Platform to produce biopharmaceuticals.
/ read more /
More Industry News
|
|
|
Biopharma News
ERS Genomics and Bioneer have revealed the signing of a license agreement for access to CRISPR/Cas9 genome editing technology intellectual property.
/ read more /
The current president of Novartis' Advanced Accelerator Applications has been appointed as the new Novartis Pharmaceuticals president.
/ read more /
More Biopharma News
|
|
|
Supplier News
CDMO iBio introduced cGMP sterile fill/finish services at its facility in Texas.
/ read more /
The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.
/ read more /
More Supplier News
|
|
|
Regulatory News
EMA has opened a three-month consultation on its draft guidelines on the quality of requirements for drug-device combination products.
/ read more /
A US District Judge in the Southern District of Florida held that the US Stem Cell Clinic of Weston, FL and US Stem Cell of Sunrise, FL adulterated and misbranded a stem cell drug product made from a patient's adipose tissue.
/ read more /
More Regulatory News
|
|
|
FEATURED TOPICS |
|
BIOPHARMACEUTICAL ANALYSIS
Making siloed data accessible across functions and to contract partners is the first step to facilitating continuous improvement and enabling use of artificial intelligence in manufacturing.
/ read more /
|
|
|
|
|
|
UPSTREAM PROCESSING
As cost and time pressures are on the rise, innovative expression systems may offer companies a good opportunity to streamline processes early on.
/ read more /
|
|
|
Events
June 18–20, 2019
June 25–26, 2019
September 3–4, 2019
more events
|
|
|
eBook
|
Experts share insight and advice for conducting CMC due diligence with contract development organizations, using multiple attributes methods to monitor quality attributes, and strategies for using specialized services for biopharmaceutical development applications.
|
|
|
|
|
